Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
THEMISMED.NS
HoldHot AirThemis Medicare Limited · Healthcare · India · $129M · Avg Vol: $311K/d
62
StockRankGet insider-trade alerts
Q
49
V
32
M
76
P/E (TTM)
30.6x
ROE
0.3%
D/E
0.3x
Dividend %
0.4%
COMPANY DESCRIPTION
Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally.
FINANCIAL SUMMARY (INR)
| Year | 2023 | 2024 | 2025 | 2026 | CAGR | TTM |
|---|---|---|---|---|---|---|
| Revenue | 3.4B | 3.8B | 4.1B | 3.4B | -0.2% | 3.3B |
| EPS (INR) | 6.18 | 4.73 | 3.24 | 0.12 | -73.1% | 4.34 |
| Shares | 92.0M | 92.0M | 92.0M | 92.1M | +0.1% | 92.1M |
| Debt | 923.8M | 957.9M | 829.9M | 1.0B | 2.7% | 1.0B |
| Equity | 3.4B | 3.8B | 4.0B | 4.0B | 5.5% | — |
| Op CF | 160.9M | 220.9M | 347.1M | -32.7M | 46.9% | -32.7M |
| Inv CF | -239.6M | -159.5M | -121.7M | -25.4M | — | — |
| Fin CF | 1.4M | -87.7M | -259.0M | 37.9M | — | — |
Loading 1Y...
PRICE (1Y)+23.7%
SMA 50SMA 200
Close
$1.40
RSI (14)
79.2
52W High
$1.56
From 52W High
0.9%
SCORE BREAKDOWN
Quality
49
ROIC
15.2%83.6
ROE
0.3%44.8
GP/Assets
32.9%68.1
Op. Margin
-63.2%19.5
FCF/Assets
-1.4%41.9
Piotroski
25.9
Int. Cover
5.9x53.9
D/E Ratio
0.25x45.5
Current Ratio
1.84x35.2
Value
32
P/E (TTM)
30.6x39.5
EV/EBITDA
-31.3x25.0
P/FCF
—N/A
P/B
3.1x45.3
P/S
3.7x50.8
Div Yield
0.4%11.1
Momentum
76
52W High %
90%83.5
RS 6M
67%93.5
SMA 50/200
1.15x83.0
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
—N/A
Q Growth
—N/A
FUNDAMENTALS
Market Cap
$129M
P/E (Forward)
—
Gross Margin
59.3%
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of THEMISMED.NS are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| THEMISMED.NS | Themis Medicare Limited(you) | $129M | 62 | Hold |
| BAJAJHCARE.NS | Bajaj HealthCare Limited | $120M | 59 | Hold |
| AMRUTANJAN.NS | Amrutanjan Health Care Limited | $153M | 53 | Hold |
| WANBURY.NS | Wanbury Limited | $91M | 69 | Buy |
| ZIMLAB.NS | ZIM Laboratories Limited | $73M | 67 | Buy |
| KILITCH.NS | Kilitch Drugs (India) Limited | $69M | 58 | Hold |
| INDOCO.NS | Indoco Remedies Limited | $237M | 57 | Hold |
| BAFNAPH.NS | Bafna Pharmaceuticals Limited | $77M | 55 | Hold |
| BETA.NS | Beta Drugs Limited | $228M | 72 | Buy |
| SIGACHI.NS | Sigachi Industries Limited | $140M | 39 | Hold |
Peer medians: ROE 11.9% · P/E 42.8x · Gross margin 59.4%